Literature DB >> 16647160

Synthesis, structure, toxicological and pharmacological investigations of 4-hydroxycoumarin derivatives.

Ilia Manolov1, Caecilia Maichle-Moessmer, Nicolay Danchev.   

Abstract

Twenty 4-hydroxycoumarin derivatives were synthesized. Five of them are described for the first time. The X-ray crystal structure analysis of 3,3'-(2,3,4-trimethoxyphenylmethylene)bis-(4-hydroxy-2H-1-benzopyran-2-one) (7) and 3,3'-(3,5-dimethoxy-4-hydroxyphenylmethylene)bis-(4-hydroxy-2H-1-benzopyran-2-one) (9) confirmed the structure of these compounds. A comparative pharmacological study of the anticoagulant effect with respect to Warfarin showed that the synthesized compounds have different anticoagulant activities. The most prospective compound is 3,3'-(4-chlorophenylmethylene)bis-(4-hydroxy-2H-1-benzopyran-2-one) (12) with low toxicity, very good index of absorption and dose dependent anticoagulant activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16647160     DOI: 10.1016/j.ejmech.2006.03.007

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  10 in total

1.  Modulation of S. aureus and P. aeruginosa biofilm: an in vitro study with new coumarin derivatives.

Authors:  Tapas Das; Manash C Das; Antu Das; Sukhen Bhowmik; Padmani Sandhu; Yusuf Akhter; Surajit Bhattacharjee; Utpal Ch De
Journal:  World J Microbiol Biotechnol       Date:  2018-11-08       Impact factor: 3.312

2.  Cytotoxic activity of new acetoxycoumarin derivatives in cancer cell lines.

Authors:  Musiliyu A Musa; Veera L D Badisa; Lekan M Latinwo; John Cooperwood; Andre Sinclair; Ahkinyala Abdullah
Journal:  Anticancer Res       Date:  2011-06       Impact factor: 2.480

3.  Synthesis, spectroscopic, dielectric, molecular docking and DFT studies of (3E)-3-(4-methylbenzylidene)-3,4-dihydro-2H-chromen-2-one: an anticancer agent.

Authors:  T Beena; L Sudha; A Nataraj; V Balachandran; D Kannan; M N Ponnuswamy
Journal:  Chem Cent J       Date:  2017-01-10       Impact factor: 4.215

4.  Inhibition of T24 and RT4 Human Bladder Cancer Cell Lines by Heterocyclic Molecules.

Authors:  Zhi-Feng Zhao; Kai Wang; Feng-Fu Guo; Hua Lu
Journal:  Med Sci Monit       Date:  2017-03-06

5.  Functionalized 4-hydroxy coumarins: novel synthesis, crystal structure and DFT calculations.

Authors:  Valentina Stefanou; Dimitris Matiadis; Georgia Melagraki; Antreas Afantitis; Giorgos Athanasellis; Olga Igglessi-Markopoulou; Vickie McKee; John Markopoulos
Journal:  Molecules       Date:  2011-01-07       Impact factor: 4.411

6.  Success or Failure of Chiral Crystallization of Similar Heterocyclic Compounds.

Authors:  Cyprian M Chunkang; Iris E Ikome; Emmanuel N Nfor; Yuta Mitani; Natsuki Katsuumi; Tomoyuki Haraguchi; Takashiro Akitsu
Journal:  Molecules       Date:  2020-12-02       Impact factor: 4.411

7.  7-Alkoxy-appended coumarin derivatives: synthesis, photo-physical properties, aggregation behaviours and current-voltage (I-V) characteristic studies on thin films.

Authors:  Abhijit Rudra Paul; Bapi Dey; Sudip Suklabaidya; Syed Arshad Hussain; Swapan Majumdar
Journal:  RSC Adv       Date:  2021-03-10       Impact factor: 3.361

8.  Meglumine-Promoted Eco-Compatible Pseudo-Three-Component Reaction for the Synthesis of 1,1-Dihomoarylmethane Scaffolds and Their Green Credentials.

Authors:  Manan S Patel; Jaydeepkumar N Parekh; Dipakkumar D Chudasama; Harsh C Patel; Priyanka Dalwadi; Anju Kunjadiya; Vaibhav Bhatt; Kesur R Ram
Journal:  ACS Omega       Date:  2022-08-18

9.  Efficient Catalyst One-Pot Synthesis of 7-(Aryl)-10,10-dimethyl-10,11-dihydrochromeno[4,3-b]chromene-6,8(7H,9H)-dione Derivatives Complemented by Antibacterial Activity.

Authors:  Yasameen K Al-Majedy; Ahmed A Al-Amiery; Abdul Amir H Kadhum; Abu Bakar Mohamad
Journal:  Biomed Res Int       Date:  2016-07-31       Impact factor: 3.411

10.  Crystal structure of the tri-ethyl-ammonium salt of 3-[(4-hy-droxy-3-meth-oxy-phen-yl)(4-hy-droxy-2-oxo-2H-chromen-3-yl)meth-yl]-2-oxo-2H-chromen-4-olate.

Authors:  Muhammad Ikram; Sadia Rehman; Afzal Khan; Carola Schulzke
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2018-02-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.